. Author manuscript; available in PMC: 2022 Mar 1.

Published in final edited form as: Transplant Cell Ther. 2021 Jan 7;27(3):262.e1–262.e11. doi: 10.1016/j.jtct.2021.01.004

Table 3.

Multivariate analysis of time to bloodstream infection via a transplant day-based model

Variable by Category of BSI	P-value¹

Clinically-Significant BSI
CHG	0.023
Donor Type²	0.014
Antibiotic Prophylaxis³	0.062

LCBI
CHG	0.101
Donor Type²	0.044
Antibiotic Prophylaxis³	0.109

CLABSI
CHG	0.131
Donor Type²	0.058
Antibiotic Prophylaxis³	0.096

MBI-LCBI
CHG	0.007
Donor Type²	0.011
Antibiotic Prophylaxis³	0.059

P-values obtained via multivariate analysis using the Fine-Grey sub-distributional hazard regression model analyzing time to infection from transplant day −13. Discharge, transfer, and death are considered competing risks, and CHG is treated as a continuous variable.

Donor Type: Allogeneic vs. Autologous Transplant.

Antibiotic Prophylaxis Regimen: Ciprofloxacin vs. Levofloxacin vs. Other.